2014
DOI: 10.1111/bjd.12743
|View full text |Cite
|
Sign up to set email alerts
|

Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis

Abstract: These findings suggest that skin barrier function correlates with the severity of skin inflammation and can be equally impaired in patients with FLG mutant- and wild-type AD with severe symptoms. Nevertheless, our results also suggest that patients with FLG mutant-type AD may have a higher risk of allergic sensitization compared with patients with the wild-type.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
38
0
3

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(44 citation statements)
references
References 41 publications
3
38
0
3
Order By: Relevance
“…Th2 cytokines can down-regulate filaggrin protein expression (3) and skin barrier impairment in AD patients with severe skin inflammation seems similar in patients with and without FLG mutations and correlated with the SCORAD. (4) As only patients with severe AD were included in our study (1) , we expect that at initiation of the study levels of skin barrier impairment and inflammation were comparable in the FMG and non-FMG, which is supported by similar mean SCORAD in both groups. When decreasing inflammation by immunosuppressive treatment, downregulation of FLG expression by the inflammatory infiltrate will be abrogated, therefore allowing skin barrier restoration and likely establishment of normal filaggrin protein levels in the non-FMG.…”
Section: Accepted Articlementioning
confidence: 80%
“…Th2 cytokines can down-regulate filaggrin protein expression (3) and skin barrier impairment in AD patients with severe skin inflammation seems similar in patients with and without FLG mutations and correlated with the SCORAD. (4) As only patients with severe AD were included in our study (1) , we expect that at initiation of the study levels of skin barrier impairment and inflammation were comparable in the FMG and non-FMG, which is supported by similar mean SCORAD in both groups. When decreasing inflammation by immunosuppressive treatment, downregulation of FLG expression by the inflammatory infiltrate will be abrogated, therefore allowing skin barrier restoration and likely establishment of normal filaggrin protein levels in the non-FMG.…”
Section: Accepted Articlementioning
confidence: 80%
“…The lack of difference between AD patients with or without FLG variants may be related to the fact that inflammation can downregulate filaggrin levels in the skin. A study of children and adults with AD found that skin barrier was similarly worse in severe AD patients with or without FLG variants compared to mild AD and/or healthy controls, particularly increased TEWL, decreased filaggrin immunostaining, and increased serum levels of TSLP [64].…”
Section: Irritants and Pruritogensmentioning
confidence: 99%
“…No TSLP protein secretion by NHEKs could be detected (not shown). It has previously been found in AD skin that barrier damage can also lead to TSLP production by KCs (Mocsai et al, 2014); therefore, transepidermal water loss and skin pH, representing barrier functions, were measured on SGP and SGR skin regions. No differences were detected, indicating that barrier damage is most probably not the cause of distinct TSLP production in SGR and SGP skin (not shown).…”
Section: Linoleic Acid Induces Tslp Expression In Keratinocytesmentioning
confidence: 99%